A detailed history of Vanguard Group Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,397,897 shares of BMEA stock, worth $8.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,397,897
Previous 1,390,756 0.51%
Holding current value
$8.78 Million
Previous $6.26 Million 125.6%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.23 - $10.1 $30,206 - $72,124
7,141 Added 0.51%
1,397,897 $14.1 Million
Q2 2024

Aug 13, 2024

BUY
$4.14 - $15.3 $104,042 - $384,504
25,131 Added 1.84%
1,390,756 $6.26 Million
Q1 2024

May 10, 2024

BUY
$13.92 - $19.5 $217,513 - $304,707
15,626 Added 1.16%
1,365,625 $20.4 Million
Q4 2023

Feb 14, 2024

BUY
$8.37 - $19.8 $88,479 - $209,305
10,571 Added 0.79%
1,349,999 $19.6 Million
Q3 2023

Nov 14, 2023

BUY
$13.44 - $23.02 $293,462 - $502,641
21,835 Added 1.66%
1,339,428 $18.4 Million
Q2 2023

Aug 14, 2023

BUY
$21.66 - $41.8 $4.94 Million - $9.54 Million
228,245 Added 20.95%
1,317,593 $28.9 Million
Q1 2023

May 15, 2023

BUY
$6.8 - $32.35 $1.56 Million - $7.4 Million
228,771 Added 26.58%
1,089,348 $33.8 Million
Q4 2022

Feb 10, 2023

BUY
$6.3 - $11.6 $361,991 - $666,524
57,459 Added 7.15%
860,577 $7.25 Million
Q3 2022

Nov 14, 2022

BUY
$9.51 - $13.61 $1.19 Million - $1.71 Million
125,311 Added 18.49%
803,118 $7.85 Million
Q2 2022

Aug 12, 2022

SELL
$3.0 - $12.03 $260,958 - $1.05 Million
-86,986 Reduced 11.37%
677,807 $8.12 Million
Q1 2022

May 13, 2022

BUY
$4.39 - $9.03 $333,389 - $685,765
75,943 Added 11.02%
764,793 $3.41 Million
Q4 2021

Feb 14, 2022

BUY
$7.22 - $12.72 $1.41 Million - $2.48 Million
194,759 Added 39.42%
688,850 $5.13 Million
Q3 2021

Nov 12, 2021

BUY
$10.0 - $15.99 $1.67 Million - $2.66 Million
166,616 Added 50.88%
494,091 $5.92 Million
Q2 2021

Aug 13, 2021

BUY
$13.65 - $20.93 $4.47 Million - $6.85 Million
327,475 New
327,475 $5.11 Million

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $184M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.